Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
You Can See Our WSSF Aggressive Growth Portfolio For May 2025 Here.
We designed our TSINetwork Ratings to give you an idea of the investment quality and risk in stocks we recommend, so you can build a portfoli...
Walmart’s U.S. stores get about a third of their merchandise from China, Mexico and other countries. However, the company’s large size should make it easier to re-negotiate costs with its suppliers to offset the impact of new U.S. tariffs. Meantime, Walmart’s ongoing investments in its online and advertising businesses will take its earnings higher over the next few years.
WALMART INC....
To offset its exposure to tariffs, the company now plans to cut 2% of its workforce....
AGILENT TECHNOLOGIES INC....
RTX’s revenue in the first quarter of 2025 rose 5.2%, to $20.31 billion from $19.31 billion a year earlier....
ELI LILLY & CO., $757.18, is still a buy. The company (New York symbol LLY; TSINetwork Rating: Above Average) (www.lilly.com; Shares outstanding: 948.0 million; Market cap: $717.8 billion; Dividend yield: 0.8%) has now partnered with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial weight-loss medicine Zepbound (tirzepatide) to their patients in virtual care weight loss management programs.
The companies are directly contracting with Eli Lilly’s self-pay pharmacy, GiftHealth....